The decrease in fiscal 2023 as compared to fiscal 2022 was primarily attributable to decreases in stock-based compensation costs of $2,050,000 as stock options are being granted at lower current fair values as compared to earlier grants that are now fully vested, legal costs of $1,492,000 related to the litigation with Venn Therapeutics, LLC, $773,000 in reduced premiums associated with insurance policies, and $640,000 in consulting costs for various consultants who supported finance, business development, and information technology
Wait until initial wound closure has occurred
Researchers should follow all storage recommendations provided with the product and avoid excessive heat, moisture, direct sunlight, and environmental contamination
Glucose-induced cAMP elevation in -cells involves amplification of constitutive and glucagon-activated GLP-1 receptor signalling
Anim Models Exp Med